View in EDS

Response to Zidovudine/Didanosine-Containing Combination Antiretroviral Therapy Among HIV-1 Subtype C--Infected Adults in Botswana: Two-Year Outcomes from a Randomized Clinical Trial.

Saved in:

Bibliographic Details
Title:	Response to Zidovudine/Didanosine-Containing Combination Antiretroviral Therapy Among HIV-1 Subtype C--Infected Adults in Botswana: Two-Year Outcomes from a Randomized Clinical Trial.
Authors:	Bussmann, Hermann^1,2, Wester, C. William^1,2,3, Thomas, Ann⁴, Novitsky, Vladimir^1,2, Okezie, Reginald¹, Muzenda, Tanaka¹, Gaolathe, Tendani^1,5, Ndwapi, Ndwapi^1,5, Mawoko, Norah¹, Widenfelt, Erik¹, Moyo, Sikhulile¹, Musonda, Rosemary^1,2, Mine, Madisa⁵, Makhema, Joseph^1,2, Moffat, Howard^1,2, Essex, Max^1,2, DeGruttola, Victor⁴, Marlink, Richard G.^1,2 marlink@hsph.harvard.edu
Source:	JAIDS: Journal of Acquired Immune Deficiency Syndromes. 5/1/2009, Vol. 51 Issue 1, p37-46. 10p.
Database:	Academic Search Ultimate

Description
ISSN:	15254135
DOI:	10.1097/QAI.0b013e31819ff102